Treatment Access

At Ardelyx, we want to help ensure that any patient who needs and is prescribed one of our medicines is not limited by access or affordability challenges. We have made strategic investments in a number of patient services programs that we believe have direct and positive impacts for our patients.

ArdelyxAssist

ArdelyxAssist™ is an innovative, high-touch patient services program that provides a broad range of access and affordability support for patients by connecting healthcare providers, Ardelyx pharmacy partners, insurance providers, and patients.

ArdelyxAssist streamlines patient and provider requests for assistance and provides patients appropriate resources, including copay assistance for eligible patients with commercial insurance. If a patient encounters a delay in obtaining coverage for our medications, is denied access to them by their insurance, or cannot afford an associated out-of-pocket expense, they may qualify for free medication under one of our patient assistance programs.

Questions about ArdelyxAssist?
Just give us a call at 617.675.ARDX (2739)

Expanded Access Policy

Currently, Ardelyx does not provide access to its investigational products outside of enrollment in clinical trials. However, Ardelyx may, in the future and in limited instances, consider expanded access to investigational products for patients residing in the United States and who may benefit from our investigational therapies currently in development. Please see www.clinicaltrials.gov for a full list of our ongoing clinical trials.